Side Step-Wise Development: Sponsors Aren’t Using FDA’s Preferred Approach To Biosimilars

 
• By Derrick Gingery
  
Steps
The approach is not working from a 'chronological' standpoint, Sarah Yim said. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics